Preventive CarePublished: September 2026·Updated: September 2026·9 min read

Weaning Off Ozempic and Wegovy: A Cardiologist's Plan

Weaning off Ozempic — or Wegovy, Mounjaro, or any GLP-1 medication — is one of the most common questions we hear once a patient has hit their target weight. The honest answer is that these drugs are not a short course of antibiotics; they treat a chronic condition, and stopping them abruptly usually undoes much of the progress. In the STEP 1 trial, people regained two-thirds of their lost weight within a year of stopping, and their blood pressure and cholesterol drifted back up with it. But a planned, gradual taper, paired with the eating, exercise and stress habits the medication made room for, gives you a genuine chance of holding your gains. Here is how we approach it in Singapore.

Dr. Peter Chang

Triple Board-Certified Cardiologist & Vascular Specialist

Can You Just Stop, or Do You Need to Taper?

Pharmacologically, you do not have to taper a GLP-1 the way you would a beta-blocker or a steroid. Semaglutide has a half-life of about a week, so it clears slowly on its own, there is no dangerous withdrawal syndrome, and gastrointestinal side effects do not rebound.

The reason we still recommend a gradual step-down for most patients is behavioural, not chemical. When the appetite-suppressing effect fades over two to three weeks, hunger and food preoccupation return, often quite sharply. Coming down through the dose tiers softens that transition and gives you time to notice early weight regain while it is still a kilogram, not five. In our Singapore practice, weaning off Ozempic is a supervised process with regular weight and appetite checks, not a date on the calendar when you simply stop.

Why the Weight Comes Back: Appetite and the Set-Point

GLP-1 medications work by mimicking a gut hormone that tells the brain you are full, slows stomach emptying, and quietens the constant background ‘food noise’ many people with obesity describe. While you take them, they also nudge the body's defended weight — the set-point the brain works to maintain — downward.

When the drug stops, the appetite signals return to their previous strength, but the metabolic adaptations that come with weight loss — a lower resting energy expenditure, higher levels of the hunger hormone ghrelin — do not fully reverse. You are hungrier and burning slightly fewer calories at the same time. This is biology, not a lack of willpower, and it is exactly why an unstructured stop tends to fail. Understanding it is the first step to planning around it, in Singapore or anywhere else.

What the Trials Show About Stopping a GLP-1

The trial evidence on stopping is remarkably consistent, and it is the first thing we walk Singapore patients through. In the STEP 1 trial extension, participants who stopped semaglutide regained about two-thirds of their lost weight within a year, and improvements in blood pressure, lipids, HbA1c and inflammation drifted back toward baseline.

The pattern repeats across the programme:

STEP 4: patients switched to placebo after 20 weeks gained 6.9% over the next year, while those who continued semaglutide lost a further 7.9% — a 14.8% difference
SURMOUNT-4 (tirzepatide): by 88 weeks, 82.5% of people who stopped had regained at least a quarter of their lost weight; those who continued kept losing
Across at least five withdrawal trials of different agents, most of the lost weight came back

How to Taper Off Ozempic or Wegovy, Step by Step

There is no single approved taper, but the approach most obesity physicians use is a stepwise reduction through the dose ladder, holding each rung for about four weeks. In Singapore we usually run this over two to four months — weaning off a GLP-1 faster is possible but leaves less room to catch regain early.

Come down one dose level at a time — for Wegovy, 2.4 to 1.7 to 1.0 to 0.5 mg — rather than halving abruptly
Hold each step for three to four weeks and weigh yourself twice a week
If weight climbs more than about 2 kg or hunger becomes unmanageable, pause at that dose or step back up
Some patients settle on a long-term low maintenance dose instead of stopping entirely — this is legitimate and common
Keep the same injection day and your food and activity routine unchanged during the taper, so the only variable is the dose

Protecting Your Heart After the Medication

As a cardiologist, my interest in these medications is not only the weight. In the SELECT trial, semaglutide cut major adverse cardiovascular events — heart attack, stroke, cardiovascular death — by 20% in people with overweight and established heart disease. Much of that benefit is tied to sustained lower weight, blood pressure, and vascular inflammation.

When you stop, those markers move in the wrong direction within months, as STEP 4 showed. That does not mean you must stay on the drug forever, but it does mean the lifestyle side has to genuinely take over the job. Before we wean anyone with cardiovascular risk in Singapore, we recheck blood pressure, an ApoB or lipid panel, HbA1c, and often repeat a coronary calcium score. We would rather adjust the plan than discover a problem at the next event.

The Habits That Have to Be in Place First

A GLP-1 buys time and appetite control; it does not build habits. The patients in Singapore who keep the weight off are the ones who used the months on treatment to make the following automatic:

Protein first: 25 to 40 g per meal to preserve muscle and blunt hunger — muscle is what keeps your metabolic rate up
Resistance training twice a week, because most people lose 20 to 40% of their weight as lean mass on a GLP-1 and want to keep what remains
150 minutes of brisk activity a week — a daily walk around the neighbourhood or the Botanic Gardens counts
Sleep and stress: under six hours of sleep and chronic stress both raise appetite and cortisol, working directly against you
Self-monitoring: a weekly weigh-in and a rough food log — the single best predictor of maintenance

When to See a Doctor in Singapore

See a doctor before you stop, not after the weight has returned. A GP or an endocrinologist can supervise a straightforward taper; if you have heart disease, diabetes, or a strong family history, a cardiologist should be part of the plan.

At our clinic at Paragon Medical Centre on Orchard Road, a review before weaning off Ozempic or Wegovy typically includes a weight and body-composition check, blood pressure, a metabolic blood panel, and a frank conversation about whether a maintenance dose makes more sense than stopping. Expect roughly SGD 150 to SGD 400 for the consultation and bloods. GLP-1 medications themselves are not Medisave-claimable for weight loss in Singapore, which is one reason many patients ask about coming off — a maintenance dose can be a middle path.

Frequently Asked Questions

Common Questions About Weaning Off Ozempic and Wegovy

Do you have to take Ozempic forever?

Not necessarily, but obesity behaves like a chronic condition, so for many people long-term treatment — often at a lower maintenance dose — makes sense. If you have reached your goal, built solid habits, and have low cardiovascular risk, a supervised taper is reasonable. If you stop with no plan, the trial data says most of the weight returns within a year.

What happens when you stop Wegovy?

Over about two to three weeks the appetite suppression fades, hunger and cravings return, and gastric emptying speeds back up. Without a maintenance plan, weight typically climbs, and blood pressure, blood sugar and cholesterol tend to follow. Gastrointestinal side effects do not rebound. A gradual taper makes the appetite transition more manageable.

Is it safe to stop Ozempic suddenly?

Medically, yes — there is no dangerous withdrawal reaction and semaglutide clears slowly on its own. The risk is practical: a sudden stop makes rebound hunger and weight regain harder to control. We recommend stepping down through the dose levels over one to three months so you can catch early regain and adjust.

How do I keep the weight off after weaning off Ozempic in Singapore?

Treat the months on the drug as training. Lock in 25 to 40 g of protein per meal, resistance training twice a week, 150 minutes of brisk activity, seven-plus hours of sleep, and a weekly weigh-in. In Singapore we also recheck your metabolic and cardiovascular markers so any drift is caught early rather than at a future clinic visit.

What is a GLP-1 maintenance dose?

Instead of stopping completely, some patients stay on the lowest dose that holds their weight — often 0.25 to 1.0 mg of semaglutide weekly. It keeps appetite control and cardiometabolic benefits largely intact at a lower cost and with fewer side effects than the full dose. For many people this is a more realistic long-term plan than full discontinuation.

Does stopping Ozempic raise cardiovascular risk again in Singapore?

Over months, yes, if the weight and blood pressure return. The SELECT trial's 20% reduction in heart attacks and strokes depended on staying on treatment. That is why we recheck blood pressure, lipids and often a calcium score before weaning anyone with heart risk in Singapore, and why the lifestyle habits have to be genuinely established first.